1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Heart Attack: new trials by email Literature Review of Heart Attack trials Research Report on Heart Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Statin, Aspirin tablet, Nexlizet - Coronary Artery Disease, Atherosclerosis | Phase 4 | Withdrawn | University of Louisville | 2024-03-01 | 2025-03-17 | |
| P3AMI Antiplatelet Trial Prasugrel, Clopidogrel, ticagrelor - Heart Attack | Phase 4 | Completed | The Royal Wolverhampton Hospitals NHS Trust | 87 | 2015-03-09 | 2020-02-10 |
Myocardial Infarction (2) · Atherosclerosis (1) · Coronary Artery Disease (1) · Non-ST Elevated Myocardial Infarction (1) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Infarction (2) · Ischemia (2) · Myocardial Ischemia (2) · Necrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1)
ALN-PCS (1) · Aspirin (1) · Atorvastatin (1) · Clopidogrel (1) · Colchicine (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Prasugrel Hydrochloride (1) · Ticagrelor (1) · eicosapentaenoic acid ethyl ester (1) · empagliflozin (1)
The Royal Wolverhampton Hospitals NHS Trust (1) · University of Louisville (1)
United Kingdom (1) · United States (1)
Dinesh Kalra, MD (1) · James Cotton, MD, FRCP (1)